Crossref
Development of LGR5-targeted antibody drugs and their prospects in tumor therapy
Chinese Bulletin of Life Sciences · 01.08.2026
DOI: 10.3724/cbls.2026110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Bulletin of Life Sciences, online erschienen am 10.08.2026. Verfasst von Tian-Hao ZHANG und 2 weiteren Autor:innen. Die Arbeit nennt 71 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
ZHANG, T., LI, T., & TAO, W. (2026). Development of LGR5-targeted antibody drugs and their prospects in tumor therapy. Chinese Bulletin of Life Sciences. https://doi.org/10.3724/cbls.2026110
Vancouver
ZHANG T, LI T, TAO W. Development of LGR5-targeted antibody drugs and their prospects in tumor therapy. Chinese Bulletin of Life Sciences. 2026. doi:10.3724/cbls.2026110
BibTeX
@article{ZHANG2026,
author = {ZHANG, Tian-Hao and LI, Tao and TAO, Wei-Hong},
title = {Development of LGR5-targeted antibody drugs and their prospects in tumor therapy},
journal = {Chinese Bulletin of Life Sciences},
year = {2026},
doi = {10.3724/cbls.2026110}
}
EUVIMED